The efficacy of imatinib for CML treatment persisted over time and long-term administration was not associated with unacceptable cumulative effects.
Nonadherence to NCCN guideline treatment recommendations was strongly associated with decreased survival from early-stage cervical cancer.
The site of cancer care may partially explain survival differences between children and AYAs with ALL.
Patients with hormone receptor-positive, HER2-negative, axillary lymph node-negative breast cancer who have a recurrence score of 11 to 25 may not benefit from chemotherapy.
Using statistical models, predictions were made for death rates from melanoma in 3 three countries and based on availability of a treatment.
Investigators studied the effects of adding antiandrogen therapy to radiotherapy on cancer control and overall survival in men with prostate cancer recurrence after radical prostatectomy.
Researchers observed a significant disparity in colon cancer mortality related to origin location, independent of confounding variables.
The United States has remained near the bottom of the Bloomberg Health-Care Efficiency Index since its creation in 2012.
The population-based EUTOS registry demonstrated high overall and progression-free survival rates among patients with chronic myeloid leukemia.
Insurance status influences overall patient survival for some cancer types, but its impact on glioblastoma multiforme (GBM) survival is well documented. This research study explored the possible impact of insurance on GBM survival.
A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.
A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.
Greatest survival benefit observed for those taking the drug before their cancer diagnosis.
Paclitaxel administered with carboplatin on a weekly basis is not associated with improved progression-free survival.
Intensive care unit survivors have higher mortality, use of hospital resources in five years after discharge.
Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.
Mortality rate changes in the United States since 1991 translate to an additional 1.7 million cancer survivors.
The longest survival time was observed for primary debulking surgery coupled with chemotherapy in an optimal timeframe.
Despite advances in treatment, finding smaller tumors has been linked to better survival results.
Nonsmokers more likely than smokers to be women and to have adenocarcinoma
Patients with metastatic nonsquamous non-small-cell lung cancer treated with nivolumab demonstrated greater survival.
A new study reveals that insurance status, marital status, and county-level income may affect survival for younger patients with AML, indicating that efforts are needed to address social factors that impact critical aspects of health.
Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.
Predictors for long-term survival include younger age, early stage, low grade, non-serous histology
Despite survival benefits, only 41 percent of suitable candidates actually receive the therapy.
A recently compiled database that compares gene expression patterns to survival data could help predict survival outcomes for a variety of cancer types.
Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysisAugust 06, 2015
[OncoTargets and Therapy] This research examines the effect of radiotherapy on overall survival in women with locally excised ductal carcinoma in situ (DCIS).
Patients that cease smoking shortly before or after a lung cancer diagnosis experience significant survival benefits.
Despite treatment advances for adolescents and young adults with cancer, they still experience a higher rate of hospitalizations than the general public.
Receptors that mediate activity of the female sex hormones (estrogen and progesterone) interact with DNA to control the growth of a large majority of breast cancers, research indicates.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- Distress Management Tool Gets an Update, Patient Version
- PSA Screening Rates Level Off in United States
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|